A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

By Decker Thomas  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

The angiogenic status of B-CLL B cells: role of the VEGF receptors

By Kay N.E.  

Leukemia Research, Vol. 28, Iss. 3, 2004-03 ,pp. : 221-222

Elsevier

Access to resources Recommend Favorite

Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9

By Chapman-Shimshoni D.   Yuklea M.   Radnay J.   Shapiro H.   Lishner M.  

Experimental Hematology, Vol. 31, Iss. 9, 2003-09 ,pp. : 779-783

Elsevier

Access to resources Recommend Favorite

Re-Establishment of a Normal Apoptotic Process as a Therapeutic Approach in B-CLL

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 261-286

Bentham Science Publishers

Access to resources Recommend Favorite

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine

By Bernasconi Paolo   Paulli Marco   Orlandi Ester   Perfetti Vittorio   Giardini Ilaria   Zibellini Silvia   Vanelli Laura   Tenore Anna   Algarotti Alessandra   Boni Marina   Amici Mara   Brusamolino Ercole   Lazzarino Mario  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 619-622

Springer Publishing Company

Access to resources Recommend Favorite